Results on prognostic value of mutations in localized gastrointestinal stromal tumors (GIST) in one single center

Revista Espanola de Enfermedades Digestivas

Volumn 104, Issue 8, 2012, Pages 405-410

  Garcés Albir, Marina ^a   Marti Obiol, Roberto ^a   López Mozos, Fernando ^a   Calabuig Fariñas, Silvia ^b   Navarro Ros, Samuel ^b   Ortega Serrano, Joaquín ^a  

^a Department of General and Digestive Surgery   (Spain)

^b HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

C kit; Gastrointestinal stromal tumors (GIST); Mutation; PDGFRA

Indexed keywords

DNA; PARAFFIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL FACTOR RECEPTOR;

ADULT; AGED; ARTICLE; C KIT GENE; CANCER PROGNOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; EXON; FEMALE; GASTROINTESTINAL STROMAL TUMOR; GENE AMPLIFICATION; GENE LOCATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MITOSIS RATE; MUTATIONAL ANALYSIS; PDGFRA GENE; POLYMERASE CHAIN REACTION; RECURRENCE FREE SURVIVAL; RETROSPECTIVE STUDY; SEQUENCE ANALYSIS; SURVIVAL RATE; TISSUE SECTION; TUMOR GENE; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 84867247410     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: 10.4321/S1130-01082012000800003     Document Type: Article

References (18)

1. Miettinen M, Lasota J. Gastrointestinal stromal tumors definition, clinical, histological, inmunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001;438:1-12.
2. Taniguchi M, Nishida T, Hirota S, Isozaki K, Ito T, Nomura T, et al. Effect of c-kit mutation on prognosis of Gastrointestinal Stromal Tumors. Cancer Res 1999;59:4297-300.
3. i Martín J, Poveda A, Llombart-Bosch A, Ramos R, López-Guerrero JA, García del Muro J, et al. Spanish Group for Sarcoma Research: Deletions affecting codons 557-558 of the c-kit gene indicate a poor pronognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS). J Clin Oncol 2005; 23:6190-8.
4. Kim TW, Lee H, Kang YK, Choe MS, Ryu MH, Chang HM, et al. Prognostic significate of c-kit mutation in localized gastrointestinal Stromal Tumors. Clin Cancer Res 2004;10:3076-81.
5. Singer S, Rubin BP, Lux ML, Chen CJ, Demetri GD, Fletcher CD, et al. Prognostic value of KIT mutation type, mitotic activity, and histologic subtype in Gastrointestinal Stromal Tumors. J Clin Oncol 2002;20:3898-905.
6. Miettinen M, Lasota J. Gastrointestinal Stromal Tumors. Review on morphology, molecular pathology, pronogsis, and differential diagnosis. Arch Pathol Lab Med 2006;130:1466-76.
7. Rubin BP, Heinrich MC, Corless CL. Gastrointestinal Stromal Tumour. Lancet 2007;369:1731-41.
8. Heinrich MC, Corless CL, Duensing A, McGreevey L, Chen CJ, Joseph N, et al. PDGFRA activating mutations in gastrointestinal stromal tumors. Science 2003;299:708-10.
9. Casali PG, Jost L, Reichardt P, Schlemmer M, Blay JY. ESMO Guidelines Working Group (2009) Gastrointestinal stromal tumours: ESMO Clinical recommendation for diagnosis, treatment and follow up. Ann Oncol 2009;20:64-7.
10. Díaz-Delgado M, Hernández-Amate A, Sánchez-León M, Pereira- Gallardo S, Prieto-Sánchez E, Jiménez-Sáenz M, et al. Multiple nonmetastasic gastrointestinal stromal tumors. Differential features. Rev Esp Enferm Dig 2010;102:489-97.
11. Fletcher CD, Berman JJ, Corless C, Gorstein F, Lasota J, Longley BJ, et al. Diagnosis of gastrointestinal stromal tumours: a consensus approach. Human Pathol 2002;33:459-65.
12. Rader AE, Avery A, Wait CL, McGreevey LS, Faigel D, Heinrich MC. Fine-needle aspiration biopsy diagnosis of gastrointestinal stromal tumors using morphology, inmunocytochemistry, and mutational analysis of c-kit. Cancer 2001;93:269-75.
13. Scarpa M, Bertin M, Ruffolo C, Polese L, D'Amico DF, Angriman I. A systematic review on the clinical diagnosis of gastrointestinal stromal tumors. J Surg Oncol 2008;98:384-92.
14. Miettinen M, Lasota J. Gastrointestinal stromal tumours: pathology and prognosis at different sites. Semin Diagn Pathol 2006;30:477-89.
15. Dematteo RP, Gold JS, Saran L, Gönen M, Liau KH, Maki RG, et al.Tumor mitotic rate, size and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST). Cancer 2008;112:608-15.
16. Demetri GD, Benjamin RS, Blanke CD, Blay JY, Casali P, Choi H, et al. NCCN Task Forceet (2007) NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST) - update of the NCCN clinical practice guidelines. J Natl Compr Canc Netw 2007;5(Supl. 2):S1-29;quiz S30.
17. NCCN. The NCCN soft tissue sarcoma clinical practice guidelines in oncology (versión 1, 2009). ©2009 National Comprehensive Cancer Network, Inc. Available at: http://www.nccn.org.
18. Martín-Broto J, Gutiérrez A, García-del-Muro X, López-Guerrero JA, Martínez-Trufero J, de Sande LM, et al. Prognosis time dependence of deletions affecting codons 557 and/or 558 of KIT gene for relapse-free survival (RFS) in localized GIST: a Spanish Group for Sarcoma Research (GEIS) study. Ann Oncol 2010;21:1552-7.